Market Closed -
Euronext Paris
11:35:05 2024-04-26 am EDT
|
5-day change
|
1st Jan Change
|
1.186
EUR
|
-1.17%
|
|
-4.35%
|
-35.86%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
922.4
|
237.7
|
168.2
|
295.6
|
178
|
114.1
|
-
|
-
|
Enterprise Value (EV)
1 |
774.5
|
73.75
|
98.88
|
98.35
|
48.63
|
-56.39
|
-109.7
|
-2.113
|
P/E ratio
|
-4.73
x
|
-1.76
x
|
-1.89
x
|
-2.69
x
|
-2.66
x
|
-1.54
x
|
-2.76
x
|
-4.48
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
70.4
x
|
25.2
x
|
32.6
x
|
65.3
x
|
12.4
x
|
17.5
x
|
23.4
x
|
5.54
x
|
EV / Revenue
|
59.1
x
|
7.83
x
|
19.1
x
|
21.7
x
|
3.38
x
|
-8.63
x
|
-22.4
x
|
-0.1
x
|
EV / EBITDA
|
-5.21
x
|
-0.71
x
|
-1.2
x
|
-1.25
x
|
-0.59
x
|
0.43
x
|
0.83
x
|
0.02
x
|
EV / FCF
|
-5.8
x
|
-0.52
x
|
-1.01
x
|
-1.85
x
|
-1.03
x
|
0.33
x
|
1.03
x
|
-0.18
x
|
FCF Yield
|
-17.2%
|
-192%
|
-99.1%
|
-54.1%
|
-97.5%
|
307%
|
96.8%
|
-562%
|
Price to Book
|
4.23
x
|
1.36
x
|
1.88
x
|
1.61
x
|
1.39
x
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
46,987
|
54,815
|
54,983
|
93,967
|
96,256
|
96,209
|
-
|
-
|
Reference price
2 |
19.63
|
4.336
|
3.059
|
3.146
|
1.849
|
1.186
|
1.186
|
1.186
|
Announcement Date
|
3/4/20
|
3/11/21
|
3/3/22
|
3/2/23
|
3/7/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
13.1
|
9.424
|
5.165
|
4.526
|
14.39
|
6.534
|
4.886
|
20.6
|
EBITDA
1 |
-148.8
|
-104.4
|
-82.28
|
-78.71
|
-82.74
|
-131
|
-132.5
|
-98.38
|
EBIT
1 |
-151.7
|
-112.6
|
-89.75
|
-90.72
|
-69.94
|
-116.7
|
-78.39
|
22.72
|
Operating Margin
|
-1,158.02%
|
-1,194.25%
|
-1,737.63%
|
-2,004.17%
|
-485.96%
|
-1,785.84%
|
-1,604.42%
|
110.32%
|
Earnings before Tax (EBT)
1 |
-153
|
-133.2
|
-144.5
|
-90.43
|
-66.54
|
-114
|
-76.7
|
23.48
|
Net income
1 |
-153.6
|
-133.2
|
-144.5
|
-90.53
|
-66.54
|
-106.7
|
-73.98
|
5.266
|
Net margin
|
-1,172.52%
|
-1,413.39%
|
-2,797.21%
|
-2,000%
|
-462.4%
|
-1,633.02%
|
-1,514.2%
|
25.56%
|
EPS
2 |
-4.150
|
-2.466
|
-1.620
|
-1.169
|
-0.6954
|
-0.7680
|
-0.4290
|
-0.2650
|
Free Cash Flow
1 |
-133.5
|
-141.5
|
-97.98
|
-53.2
|
-47.43
|
-172.9
|
-106.1
|
11.88
|
FCF margin
|
-1,019.02%
|
-1,500.93%
|
-1,896.99%
|
-1,175.25%
|
-329.59%
|
-2,646.69%
|
-2,172.33%
|
57.66%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
225.56%
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/4/20
|
3/11/21
|
3/3/22
|
3/2/23
|
3/7/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019 S2
|
2020 S1
|
2020 S2
|
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
---|
Net sales
1 |
6.038
|
7.6
|
4.067
|
1.141
|
2.653
|
2.423
|
1.488
|
2.125
|
-1.271
|
1.999
|
2.087
|
2.272
|
8.121
|
1.634
|
1.634
|
1.634
|
1.634
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
-72.37
|
-66.58
|
-44.72
|
-21.02
|
-12.71
|
-15.96
|
-23.19
|
-18.46
|
-35.44
|
-19.18
|
-22.68
|
-17.23
|
-10.91
|
-25.97
|
-28.16
|
-30.53
|
-32.03
|
Operating Margin
|
-1,198.63%
|
-876.05%
|
-1,099.59%
|
-1,841.87%
|
-479.13%
|
-658.72%
|
-1,558.08%
|
-868.85%
|
2,788.29%
|
-959.09%
|
-1,086.96%
|
-758.33%
|
-134.31%
|
-1,589.59%
|
-1,724.15%
|
-1,869.1%
|
-1,960.52%
|
Earnings before Tax (EBT)
1 |
-73.24
|
-86.54
|
-44.97
|
-20.73
|
-68.35
|
-15.82
|
-22.43
|
-17.71
|
-36.73
|
-18.63
|
-21.96
|
-15.81
|
-10.24
|
-19.03
|
-22.29
|
-26.32
|
-31.24
|
Net income
1 |
-73.79
|
-86.5
|
-44.96
|
-20.73
|
-68.35
|
-15.9
|
-22.43
|
-17.71
|
-36.75
|
-18.63
|
-21.96
|
-15.81
|
-10.24
|
-19.74
|
-23
|
-26.63
|
-30.72
|
Net margin
|
-1,222.09%
|
-1,138.16%
|
-1,105.58%
|
-1,816.55%
|
-2,576.02%
|
-656.17%
|
-1,506.8%
|
-833.51%
|
2,890.74%
|
-931.82%
|
-1,052.17%
|
-695.83%
|
-126.04%
|
-1,208.6%
|
-1,407.82%
|
-1,630.31%
|
-1,880.41%
|
EPS
2 |
-
|
-
|
-
|
-0.3795
|
-0.2347
|
-0.2855
|
-0.3407
|
-0.1844
|
-0.4244
|
-0.1999
|
-0.2359
|
-0.1609
|
-0.1006
|
-0.3290
|
-0.2100
|
-0.1550
|
-0.1370
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/4/20
|
7/31/20
|
3/11/21
|
10/26/21
|
3/3/22
|
5/2/22
|
8/1/22
|
11/3/22
|
3/2/23
|
5/4/23
|
7/31/23
|
10/31/23
|
3/7/24
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
148
|
164
|
69.3
|
197
|
129
|
170
|
224
|
116
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-133
|
-141
|
-98
|
-53.2
|
-47.4
|
-173
|
-106
|
11.9
|
ROE (net income / shareholders' equity)
|
-105%
|
-80%
|
-105%
|
-65.6%
|
-43.5%
|
-
|
-
|
-
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
|
4.640
|
3.190
|
1.630
|
1.950
|
1.330
|
-
|
-
|
-
|
Cash Flow per Share
|
-3.470
|
-2.570
|
-1.780
|
-0.6800
|
-0.4900
|
-
|
-
|
-
|
Capex
1 |
4.97
|
2.3
|
0.28
|
0.09
|
0.62
|
42
|
48.3
|
55.5
|
Capex / Sales
|
37.96%
|
24.36%
|
5.49%
|
2.08%
|
4.3%
|
642.62%
|
988.23%
|
269.55%
|
Announcement Date
|
3/4/20
|
3/11/21
|
3/3/22
|
3/2/23
|
3/7/24
|
-
|
-
|
-
|
Last Close Price
1.186
EUR Average target price
4.783
EUR Spread / Average Target +303.32% Consensus |
1st Jan change
|
Capi.
|
---|
| -35.86% | 122M | | +5.31% | 70.44B | | +10.97% | 8.94B | | -16.83% | 4.75B | | +43.48% | 4.5B | | +3.20% | 3.85B | | +18.82% | 2.38B | | -21.36% | 2.34B | | -29.67% | 2.2B | | +8.38% | 1.96B |
Specialty & Advanced Pharmaceuticals
|